Skip to content

Impact of liver fibrosis to Urease-positive Streptococcus salivarius group isolated from oral swab

Impact of liver fibrosis to Urease-positive Streptococcus salivarius group isolated from oral swab - Impact of liver fibrosis to Urease-positive Streptococcus salivarius group isolated from oral swab

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000050426
Enrollment
50
Registered
2023-02-25
Start date
2022-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic liver diseasea

Interventions

None listed

Sponsors

other
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients were required to meet the following inclusion criteria: (1) the presence of chronic liver disease, (2) men and women over twenty years old.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
the correlation between the liver fibrosis and a urease-positive S. salivarius rate in patients with CLD was evaluated.

Countries

Japan

Contacts

Public ContactHaruki Uojima

Kitasato University School of Medicine Gastroenterology

kiruha@kitasato-u.ac.jp042-778-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026